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ABSTRACT
INTRODUCTION: Carvedilol is in a class of medications called beta blockers. It works by relaxing blood ves-
sels and slowing heart rate to improve blood flow and decrease blood pressure.
AIM: The aim of this article is to develop a spectrophotometric method for the quantitative determina-
tion of carvedilol with diazonium salts, establish optimal conditions for the quantitative determination of 
carvedilol in drugs, and validate the developed methodology.
MATERIALS AND METHODS: All studies were conducted on the basis of the experimental pharmaceuti-
cal research department of the scientific medical laboratory center (NMLC) of the Zaporozhye State Medi-
cal University.
Reagents and solvents: 6.25 mg carvedilol tablets (PRANAPHARMJSC, Samara, series 20717), 12.5 mg 
Carvedilol Canon tablets (Canonpharma Production CJSC, Russia, series 060517), 25 mg Talliton tablets 
(EGIS Pharmaceuticals PLC, Hungary, series 473D0617), 25 mg Carvedilol-KV tablets (OJSC Kyiv Vitamin 
Plant, Kyiv, Ukraine, series EF 411017), diazol red 2G (NVF Sinbias), acetone, methanol, ethanol, isopropa-
nol, water.
Analytical equipment: SPECORD-200spectrophotometer (Analytic Jena AG, Germany), ULAB S131UV spec-
trophotometer, RADWAG XA 210.4Y electronic laboratory scales, Sonorex Digitec DT100H ultrasonic bath.
RESULTS: The technique of spectrophotometric determination of the quantitative content of carvedilol 
based on its reaction with red diazole in water-methanol medium has been developed. The 1:1 stoichiomet-
ric ratios of the reactive components were obtained by the methods of continuous changes and the satura-
tion method. 
CONCLUSION: A spectrophotometric method of analysis for the quantitative determination of carvedilol in 
tablets has been developed. The method is simple, fast, accurate, and reliable. This has been proven by veri-
fication characteristics (linearity, precision, correctness and sustainability). The developed methodology is 
correct and can be used in the chemical and pharmaceutical industries.
Keywords: carvedilol, diazonium salts, spectro-
photometry, validation
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INTRODUCTION
Carvedilol is in a class of medications called 
beta blockers. It works by relaxing blood vessels and 
slowing heart rate to improve blood flow and de-
crease blood pressure (1).
Carvedilol is most often determined in drugs 
and biological fluids by chromatographic (3–5) and 
spectrophotometric methods (6). Determination of 
carvedilol in tablets by direct spectrophotometry of 
methanolic solutions at a wavelength of 241 nm has 
been proposed (7). When a mixture of acetonitrile 
and water is used as a solvent in a ratio of 60:40, the 
maximum absorption is observed at a wavelength of 
332 nm (8). Determination of carvedilol in tablets by 
reaction with bromocresol purple in acetone (9), with 
bromothymol blue and bromocresol green in chlo-
roform (10, 11), with p-dimethylaminobenzaldehyde 
and p-chloranil (12) are described. Determination of 
carvedilol by reaction with methyl orange and subse-
quent extraction with chloroform of the formed ionic 
associate is proposed by Wislous O.O. et. al. (13). Re-
action of ionic associate formation with bromocresol 
green is the basis of another extraction-photometric 
method (14). From the literature data analysis, it fol-
lows that the existing methods of spectrophotomet-
ric determination of carvedilol are not always selec-
tive, sensitive, express, and satisfy the provisions of 
“green chemistry”. So, the development of new meth-
ods is relevant.
AIM
The purpose of the present work was to devel-
op a high-sensitivity, easy-to-execute, and valid spec-
trophotometric method for the quantitative determi-
nation of carvedilol in tablets based on the reaction 
with diazonium salts. The following tasks were set to 
achieve the goal:
  to establish the optimal conditions for the pho-
tometric reactions of carvedilol with diazole 
red 2G and calculate the analytical sensitivity 
parameters;
  develop a method for the quantitative deter-
mination of carvedilol in the pharmaceutical 
forms;
  validate the developed methodology.
MATERIALS AND METHODS
All reagents were analytical grade and includ-
ed:6.25 mg carvedilol tablets (PRANAPHARMJSC, 
Samara, series 20717), 12.5 mg Carvedilol Canon 
tablets (Canonpharma Production CJSC, Russia, se-
ries 060517), tablets Talliton 25 mg (EGIS Pharma-
ceuticals PLC, Hungary, series 473D0617), 25 mg 
Carvedilol-KV tablets (OJSC Kyiv Vitamin Plant, 
Kyiv, Ukraine, series EF 411017), diazol red 2G (NVF 
Sinbias), acetone, methanol, ethanol, isopropanol, 
water.
SPECORD-200 spectrophotometer (Analytic 
Jena AG, Germany) and ULAB S131UV spectropho-
tometer were used to obtain the spectra and the ab-
sorbance measurements.
Other apparatuses included RADWAG XA 
210.4Y electronic laboratory scales and Sonorex 
Digitec DT100H ultrasonic bath. 
All studies were conducted on the basis of the 
experimental pharmaceutical research department 
of the scientific medical laboratory center (NMLC) 
of the Zaporozhye State Medical University.
Procedure for the Assay of Carvedilol
Preparation of carvedilol standard solution: 
0.016 g of carvedilol, dissolved in methanol, was 
placed in a 100.00 mL volumetric flask, the flask was 
filled up to the mark with methanol, and then all was 
mixed.
Preparation of the compensating solution: 2.00 
mL of 0.2% solution of diazole red 2G in methanol 
were transferred into a volumetric flask of 10.00 mL, 
0.20 mL of 0.1% sodium carbonate solution, incubat-
ed for 10 min, were added,2.00 mL methanol were 
added, the flask was filled up to the mark with water, 
then all was mixed.
An aliquot of carvedilol (0.0544-0.5660 g) was 
placed in a 10.00 mL volumetric flask, 2.00 mL of 
0.2% solution of diazole red 2Gin methanol were 
Fig. 1. Carvedilol—1-(9H-Carbazol-4-yloxy)-3-[[2-(2-me-
thoxyphenoxy)ethyl]amino]-2-propanol (2).
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added, 0.20 mL of 0.1% solution of sodium carbon-
ate, incubated for 10 min, were added, 2.00 mL of 
methanol were added, the flask was filled up to the 
mark with water, then all was mixed. The absorption 
of the resulting solution was measured against the 
background of the compensation solution at an ana-
lytical wavelength of 385 nm.
Procedure for the Assay of Carvedilol in Phar-
maceutical Preparations
The exact portion of a thoroughly ground tablet 
mass of 6.25 mg carvedilol (about 0.5 g), 25 mg Tal-
liton (about 0.1 g), 12.5 mg Carvedilol Canon (about 
0.2 g), and 25 mg Carvedilol-KV (about 0.1 g), was 
transferred to a volumetric flask of 100.00 mL, the 
flask was filled up to the mark with methanol, incu-
bated in an ultrasonic bath for 2 minutes. The solu-
tion was then filtered through a paper filter (“Blue 
Ribbon”), discarding the first portions of the fil-
trate. A total of1.00 mL of solution from the follow-
ing portions of the filtrate was transferred to a volu-
metric flask of 10.00 mL, 2.00 mL of 0.2% solution of 
diazole red 2Gin methanol were added, 0.20 mL of 
0.1% sodium carbonate solution, incubated 10 min, 
were added, 2.00 mL of methanol were added, the 
flask was filled up to the mark with water, then all 
was mixed. The absorption of colored solutions was 
measured against the background of the compensa-
tion solution at an analytical wavelength of 385 nm. 
In parallel, the experiment was conducted with 1.00 
mL of carvedilol standard solution. The calculation 
of the active substance content was carried out ac-
cording to the conventional formula.
RESULTS AND DISCUSSION
Factors influencing the rate and complete-
ness of the reaction (solvent, reagent amount, reac-
tion time and stability of the analyzed solutions over 
time) were studied at the stage of the development of 
the method. 
The solvent was chosen taking into account the 
solubility of carvedilol and diazole red 2G, as well as 
the maximum yield of the reaction product, i.e. the 
maximum value of optical density. The amount of 
reagent was also chosen according to the maximum 
value of the optical density.
It was found experimentally that the reaction 
took place in aqueous-methanol medium at room 
temperature using 0.2% solution of diazole red 2G as 
a color reagent with the formation of a colored reac-
tion product with a maximum absorption at 385 nm 
(Fig. 2).
Determination of the amount of reagent re-
quired for the completeness of the reaction was set 
experimentally based on the maximum yield of the 
reaction product, i.e. the maximum value of opti-
cal density. To do this, 1.00 mL of the test drug so-
lution and 0.50; 1.00; 1.50; 2.00, and 2.50 mL of re-
agent were added to a 10.00 mL volumetric flasks. 
The absorbance of the test solutions was measured 
against the background of compensating solutions at 
the above wavelength.
The external factors that can affect optical den-
sity (stability of the analyzed solutions in time, the 
Fig. 2. Graph of the dependence of the optical density of 
the solution after the reaction of carvedilol with diazole 
red 2G
Fig. 3. The absorption spectrum of the reaction product of 
carvedilol with diazole red 2G
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amount of added reagents and the temperature of the 
heated solutions of the analyzed solutions) were stud-
ied. It was found that analyzed solutions were stable 
at least 45 minutes (Fig. 3). The influence of other 
factors is described above.
Stoichiometry of the Reaction
Stoichiometric coefficients between carvedilol 
and diazole red 2G were established by the method 
of continuous changes (method of isomolar series) 
and by the method of saturation (method of molar 
ratios) (15).
The method of isomolar series is based on de-
termining the ratios of isomolar concentrations of 
reactants, which corresponds to the maximum yield 
of compounds formed as a result of the reaction. To 
perform the assay, solutions of the reagent and test 
drug substance of the same molar concentration 
(0.0004 M) were prepared and mixed in anti-bath ra-
tios, while the total volume of the solution remained 
unchanged. The reaction was carried out accord-
ing to the developed method. Based on the obtained 
data, a graph of the dependence of the optical density 
on the ratio of the volumes of the components of the 
isomolar series was constructed (Fig. 4).
The method of molar ratios determines the de-
pendence of the optical density on the concentration 
of one of the components of the reaction mixture at 
a constant concentration of the second component 
and vice versa. The inflection point on the satura-
tion curve is equal to the stoichiometric coefficient of 
the component whose concentration is varied (Figs. 
5a, 5b).
As can be seen from Fig. 4 and Fig. 5a, b, the 
stoichiometric ratios of the carvedilol-diazole red 
2G reacting components, obtained by both methods, 
agree with each other and are 1:1.
Determination of Validation Characteristics
In accordance with the requirements of the State 
Pharmacopoeia of Ukraine (16), the methods for 
quantitative determination of drugs should be vali-
dated. Validation of methods of quantitative analysis 
of drugs is the main condition for ensuring the reli-
ability of the analysis results. Therefore, to verify the 
correctness of the proposed method, the main vali-
dation characteristics were determined, namely, lin-
earity, precision, accuracy, and robustness (17).
Fig. 4. Graph of the dependence of the optical density on 
the composition of the isomolar solution (V1—0.0004 M 
carvedilol solution, V2—0.0004 M solution of diazole red 
2G) at 385 nm
Fig. 5. a. Saturation curve of carvedilol solution at a constant concentration of the reagent solution; b. saturation curve 
of the reagent solution at a constant concentration of carvedilol solution
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Linearity
The determination of the linearity was carried 
at the concentration range according to the main law 
of light absorption, namely 1–2 mg/100 mL. Stan-
dard solution of carvedilol was diluted for obtaining 
the solutions with known concentration, which were 
analyzed according to the general procedure. The de-
pendence of the optical density on the concentration 
of the analyzed solution is described in Fig. 6.
The linearity of the method was confirmed 
throughout the concentration range indicated above 
(Table 1). Thus, the concentration range of applica-
tion of the technique was 75–125% of the nominal 
content of carvedilol in the drug.
Precision
The precision of the method was estimated by 
measuring nine replicate samples of carvedilol. The 
assays gave satisfactory results; the one-way confi-
dence interval Δz did not exceed the maximum per-
missible uncertainty of the analysis ∆AS, so the meth-
od was accurate at the level of convergence (Table 2). 
This level of precision of the proposed method was 
adequate for the quality control analysis of carvedilol 
in its pharmaceutical dosage forms.
Correctness
The correctness of the method has been de-
termined via the method of additions. Different 
amounts of carvedilol solution were added to three 
equal sample dosage forms and analyzed three times. 
The estimated criterion of practical insignificance 
for all dosage forms did not exceed the maximum 
permissible uncertainty analysis (Table 3).
CONCLUSION
A validated spectrophotometric method for 
carvedilol assay in tablets has been developed. The 
method is simple, rapid, accurate, and reliable for the 
determination of carvedilol in tablets without inter-
Fig. 6. Graph of the dependence of optical density on the 
concentration of carvedilol
Table 1. Spectrophotometric characteristics and statistical data of the regression equations
Table 2. Evaluation of the accuracy and precision of the proposed procedure
Parameter Value
Molar absorption index, ε 21000
Sandel’s ratio, WS 0.011275
Opening minimum, Cmin, (μg/mL) 0.97
Linear regression equation Y = bX + a
Angular coefficient, b ± (Sb) 0.9947 (±0.0037)
Free term of linear regression, a ± (Sa) 0.5741 (±0.3653)
Residual standard deviation, Sx, 0 0.1835
Correlation coefficient, r 0.9999
Formulation Names Z̅% (n=9) SZ% ∆AS ∆Z
Carvedilol 6.25 mg 100.53 0.23 3.2 0.43
Carvedilol Canon 12.5 mg 100.01 0.36 3.2 0.67
Talliton 25 mg 100.23 0.66 1.6 1.23
Carvedilol-KV 25 mg 100.78 0.82 1.6 1.52
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ference from the common excipients. It was proved 
by the validation characteristics (linearity, preci-
sion, correctness, and robustness) that the developed 
methodology is correct and can be applied in the 
chemical and pharmaceutical industry.
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Table 3. Correctness of the results of quantitative determination of carvedilol
Formulation Names Z̅% (n=9) Sz % ∆Z Z̅ - 100
Carvedilol 6.25 mg 100.96 0.30 0.56 0.96
Carvedilol Canon 12.5 mg 100.23 0.28 0.52 0.23
Talliton 25 mg 100.18 0.33 0.61 0.18
Carvedilol-KV 25 mg 100.11 0.91 1.69 0.11
